MENINGOCOCCAL VACCINE STUDY
Study: A Phase IIb, Randomized, Observer-Blind study to Describe the Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents For more information, call Cyn3rgy Research at 503 907 2179 x2 |
Sign Up for one of our studies!
|